V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN) Peptide
Quick Overview for V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN) Peptide (ABIN937504)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- DPTSNKQQRP VPESQLLPGQ RFQTKDPEEQ GDIVVALYPY DGIHPDDLSF
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LYN antibody,
Alternative Names: LYN control peptide, LYN antibody Blocking Peptide, Anti-LYN Blocking Peptide, V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog Blocking Peptide, FLJ26625 Blocking Peptide, JTK8 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- LYN (V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN))
-
Background
- LYN down regulates expression of stem cell growth factor receptor (KIT).LYN acts as an effector of EpoR (erythropoietin receptor) in controlling KIT expression and may play a central role in erythroid differentiation during the switch between proliferation and maturation.
-
Molecular Weight
- 58 kDa
Target
-